Home
>
National Drug Code (NDC)
>
ERY-TAB
ERY-TAB - 42549-535-30 - (Erythromycin)
Drug Information of ERY-TAB
| Product NDC: | 42549-535 |
| Proprietary Name: | ERY-TAB |
| Non Proprietary Name: | Erythromycin |
| Active Ingredient(s): | 333 mg/1 & nbsp; Erythromycin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ERY-TAB
| Product NDC: | 42549-535 |
| Labeler Name: | STAT Rx USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA062298 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110418 |
Package Information of ERY-TAB
| Package NDC: | 42549-535-30 |
| Package Description: | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (42549-535-30) |
NDC Information of ERY-TAB
| NDC Code | 42549-535-30 |
| Proprietary Name | ERY-TAB |
| Package Description | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (42549-535-30) |
| Product NDC | 42549-535 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Erythromycin |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20110418 |
| Marketing Category Name | ANDA |
| Labeler Name | STAT Rx USA LLC |
| Substance Name | ERYTHROMYCIN |
| Strength Number | 333 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |
